These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

267 related articles for article (PubMed ID: 31099768)

  • 1. Tuberculosis Screening, Testing, and Treatment of U.S. Health Care Personnel: Recommendations from the National Tuberculosis Controllers Association and CDC, 2019.
    Sosa LE; Njie GJ; Lobato MN; Bamrah Morris S; Buchta W; Casey ML; Goswami ND; Gruden M; Hurst BJ; Khan AR; Kuhar DT; Lewinsohn DM; Mathew TA; Mazurek GH; Reves R; Paulos L; Thanassi W; Will L; Belknap R
    MMWR Morb Mortal Wkly Rep; 2019 May; 68(19):439-443. PubMed ID: 31099768
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Screening of health-care workers for latent tuberculosis infection in a Tertiary Care Hospital.
    Janagond AB; Ganesan V; Vijay Kumar GS; Ramesh A; Anand P; Mariappan M
    Int J Mycobacteriol; 2017; 6(3):253-257. PubMed ID: 28776523
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Interferon-gamma release assays for tuberculosis screening of healthcare workers: a systematic review.
    Zwerling A; van den Hof S; Scholten J; Cobelens F; Menzies D; Pai M
    Thorax; 2012 Jan; 67(1):62-70. PubMed ID: 21228420
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Position statement on interferon-γ release assays for the detection of latent tuberculosis infection.
    Bastian I; Coulter C;
    Commun Dis Intell Q Rep; 2017 Dec; 41(4):E322-E336. PubMed ID: 29864386
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Screening of latent tuberculosis infection among health care workers working in Hajj pilgrimage area in Saudi Arabia, using interferon gamma release assay and tuberculin skin test.
    Bukhary ZA; Amer SM; Emara MM; Abdalla ME; Ali SA
    Ann Saudi Med; 2018; 38(2):90-96. PubMed ID: 29620541
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Essential Components of a Public Health Tuberculosis Prevention, Control, and Elimination Program: Recommendations of the Advisory Council for the Elimination of Tuberculosis and the National Tuberculosis Controllers Association.
    Cole B; Nilsen DM; Will L; Etkind SC; Burgos M; Chorba T
    MMWR Recomm Rep; 2020 Jul; 69(7):1-27. PubMed ID: 32730235
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The use of an interferon-gamma release assay to screen for pediatric latent tuberculosis infection in the eastern region of the Emirate of Abu Dhabi.
    Al Mekaini LA; Al Jabri ON; Narchi H; Kamal SM; Mabrook A; Al Kuwaiti MM; Sheek-Hussein MM; Souid AK; Alsuwaidi AR
    Int J Infect Dis; 2014 Jun; 23():4-7. PubMed ID: 24657274
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mycobacterium Tuberculosis Infection, Immigration Status, and Diagnostic Discordance: A Comparison of Tuberculin Skin Test and QuantiFERON-TB Gold In-Tube Test Among Immigrants to the U.S.
    Wilson FA; Miller TL; Stimpson JP
    Public Health Rep; 2016; 131(2):303-10. PubMed ID: 26957665
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Tuberculosis screening in Portuguese healthcare workers using the tuberculin skin test and the interferon-gamma release assay.
    Torres Costa J; Sá R; Cardoso MJ; Silva R; Ferreira J; Ribeiro C; Miranda M; Plácido JL; Nienhaus A
    Eur Respir J; 2009 Dec; 34(6):1423-8. PubMed ID: 19948911
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Tuberculosis Screening, Testing, and Treatment of US Health Care Personnel: ACOEM and NTCA Joint Task Force on Implementation of the 2019 MMWR Recommendations.
    Thanassi W; Behrman AJ; Reves R; Russi M; Swift M; Warkentin J; Miyakawa R; Wegener D; Budnick L; Murray E; Scarpita A; Hurst BJ; Foster-Chang S; Mathew T; Gruden M; Higashi J; Hudson TW
    J Occup Environ Med; 2020 Jul; 62(7):e355-e369. PubMed ID: 32730040
    [TBL] [Abstract][Full Text] [Related]  

  • 11. High incidence of latent tuberculous infection among South African health workers: an urgent call for action.
    McCarthy KM; Scott LE; Gous N; Tellie M; Venter WD; Stevens WS; Van Rie A
    Int J Tuberc Lung Dis; 2015 Jun; 19(6):647-53. PubMed ID: 25946353
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Contribution of a heparin-binding haemagglutinin interferon-gamma release assay to the detection of Mycobacterium tuberculosis infection in HIV-infected patients: comparison with the tuberculin skin test and the QuantiFERON-TB Gold In-tube.
    Wyndham-Thomas C; Dirix V; Schepers K; Martin C; Hildebrand M; Goffard JC; Domont F; Libin M; Loyens M; Locht C; Van Vooren JP; Mascart F
    BMC Infect Dis; 2015 Feb; 15():59. PubMed ID: 25886172
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prevalence of latent tuberculosis infection in BCG-vaccinated healthcare workers by using an interferon-gamma release assay and the tuberculin skin test in an intermediate tuberculosis burden country.
    Hung WT; Lee SS; Sy CL; Wu KS; Chen JK; Tsai HC; Chen YS
    J Microbiol Immunol Infect; 2015 Apr; 48(2):147-52. PubMed ID: 24071516
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Interferon-γ release assay as a sensitive diagnostic tool of latent tuberculosis infection in patients with HIV: a cross-sectional study.
    Klautau GB; da Mota NVF; Salles MJC; Burattini MN; Rodrigues DS
    BMC Infect Dis; 2018 Nov; 18(1):585. PubMed ID: 30453903
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Guidelines for the Treatment of Latent Tuberculosis Infection: Recommendations from the National Tuberculosis Controllers Association and CDC, 2020.
    Sterling TR; Njie G; Zenner D; Cohn DL; Reves R; Ahmed A; Menzies D; Horsburgh CR; Crane CM; Burgos M; LoBue P; Winston CA; Belknap R
    MMWR Recomm Rep; 2020 Feb; 69(1):1-11. PubMed ID: 32053584
    [TBL] [Abstract][Full Text] [Related]  

  • 16. IFN-γ release assay versus tuberculin skin test for monitoring TB infection in healthcare workers.
    Nienhaus A; Ringshausen FC; Costa JT; Schablon A; Tripodi D
    Expert Rev Anti Infect Ther; 2013 Jan; 11(1):37-48. PubMed ID: 23428101
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Tuberculosis epidemiology, diagnosis and infection control recommendations for dental settings: an update on the Centers for Disease Control and Prevention guidelines.
    Cleveland JL; Robison VA; Panlilio AL
    J Am Dent Assoc; 2009 Sep; 140(9):1092-9. PubMed ID: 19723941
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Evaluation of the usefulness of interferon-gamma release assays and the tuberculin skin test for the detection of latent Mycobacterium tuberculosis infections in Korean rheumatic patients who are candidates for biologic agents.
    Kim JH; Won S; Choi CB; Sung YK; Song GG; Bae SC
    Int J Rheum Dis; 2015 Mar; 18(3):315-22. PubMed ID: 25351815
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Guidelines for preventing the transmission of Mycobacterium tuberculosis in health-care settings, 2005.
    Jensen PA; Lambert LA; Iademarco MF; Ridzon R;
    MMWR Recomm Rep; 2005 Dec; 54(RR-17):1-141. PubMed ID: 16382216
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparison of a commercial interferon-gamma release assay and tuberculin skin test for the detection of latent tuberculosis infection in Hong Kong arthritis patients who are candidates for biologic agents.
    So H; Yuen CS; Yip RM
    Hong Kong Med J; 2017 Jun; 23(3):246-50. PubMed ID: 28126971
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.